GMED vs. NEM
GMED (Globus Medical, Inc.) and NEM (Newmont Corporation) are both stocks. GMED operates in Medical Devices (Healthcare), while NEM operates in Gold (Basic Materials). Over the past 10 years, GMED returned 12.07%/yr vs 11.79%/yr for NEM. At a 0.12 correlation, their price movements are largely independent.
Performance
GMED vs. NEM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, GMED achieves a -10.54% return, which is significantly lower than NEM's -4.15% return. Both investments have delivered pretty close results over the past 10 years, with GMED having a 12.07% annualized return and NEM not far behind at 11.79%.
GMED
- 1D
- 1.92%
- 1M
- -2.99%
- 6M
- -17.32%
- YTD
- -10.54%
- 1Y
- 36.75%
- 3Y*
- 8.91%
- 5Y*
- -0.63%
- 10Y*
- 12.07%
NEM
- 1D
- 0.51%
- 1M
- -2.36%
- 6M
- -12.19%
- YTD
- -4.15%
- 1Y
- 60.16%
- 3Y*
- 32.96%
- 5Y*
- 11.48%
- 10Y*
- 11.79%
GMED vs. NEM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
GMED Globus Medical, Inc. | -10.54% | 5.56% | 55.21% | -28.25% | 2.87% | 10.70% | 10.77% | 36.04% | 5.30% | 65.66% |
NEM Newmont Corporation | -4.15% | 172.82% | -7.83% | -8.76% | -20.77% | 7.40% | 40.28% | 30.52% | -6.15% | 10.91% |
Correlation
The correlation between GMED and NEM is 0.23, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.23 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.21 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.14 |
Correlation (All Time) Calculated using the full available price history since Aug 3, 2012 | 0.12 |
The correlation between GMED and NEM shifts across timeframes, from 0.12 (all time) to 0.23 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
GMED:
$10.53B
NEM:
$101.73B
GMED:
$4.28
NEM:
$7.15
GMED:
18.23
NEM:
13.33
GMED:
0.19
NEM:
0.35
GMED:
3.45
NEM:
4.07
GMED:
$3.10B
NEM:
$17.23B
GMED:
$1.58B
NEM:
$8.97B
GMED:
$803.34M
NEM:
$13.78B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
GMED vs. NEM — Risk / Return Rank
GMED
NEM
GMED vs. NEM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Globus Medical, Inc. (GMED) and Newmont Corporation (NEM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| GMED | NEM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.57 | ||
| Sortino ratioReturn per unit of downside risk | +0.03 | ||
| Omega ratioGain probability vs. loss probability | 1.21 | 1.23 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | 1.60 | 2.09 | -0.49 |
| Martin ratioReturn relative to average drawdown | 3.87 | 4.81 | -0.95 |
Loading charts...
Drawdowns
GMED vs. NEM - Drawdown Comparison
The maximum GMED drawdown since its inception was -47.91%, smaller than the maximum NEM drawdown of -81.30%. Use the drawdown chart below to compare losses from any high point for GMED and NEM.
Loading charts...
Drawdown Indicators
| GMED | NEM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -47.91% | -81.30% | +33.39% |
Max Drawdown (1Y)Largest decline over 1 year | -22.10% | -29.39% | +7.29% |
Max Drawdown (3Y)Largest decline over 3 years | -44.40% | -36.57% | -7.83% |
Max Drawdown (5Y)Largest decline over 5 years | -47.91% | -62.40% | +14.49% |
Max Drawdown (10Y)Largest decline over 10 years | -47.91% | -62.40% | +14.49% |
Current DrawdownCurrent decline from peak | -19.32% | -27.47% | +8.15% |
Average DrawdownAverage peak-to-trough decline | -15.33% | -41.34% | +26.01% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.13% | 12.73% | -3.60% |
Volatility
GMED vs. NEM - Volatility Comparison
Globus Medical, Inc. (GMED) and Newmont Corporation (NEM) have volatilities of 13.69% and 14.14%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| GMED | NEM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.69% | 14.14% | -0.45% |
Volatility (6M)Calculated over the trailing 6-month period | 25.33% | 37.29% | -11.96% |
Volatility (1Y)Calculated over the trailing 1-year period | 49.46% | 47.74% | +1.72% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.27% | 38.15% | +0.12% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 35.68% | 35.73% | -0.05% |
Dividends
GMED vs. NEM - Dividend Comparison
GMED has not paid dividends to shareholders, while NEM's dividend yield for the trailing twelve months is around 1.07%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GMED Globus Medical, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NEM Newmont Corporation | 1.07% | 1.00% | 2.69% | 3.87% | 4.66% | 3.55% | 1.74% | 3.31% | 1.62% | 0.67% | 0.37% | 0.56% |
Financials
GMED vs. NEM - Financials Comparison
This section allows you to compare key financial metrics between Globus Medical, Inc. and Newmont Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
GMED and NEM have a correlation of 0.23, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NEM has higher volatility (14.14%) compared to GMED (13.69%). In terms of maximum drawdown, GMED dropped -47.91% vs NEM's -81.30%.
NEM currently has the higher Sharpe Ratio (1.29 vs 0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for GMED and NEM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer